Want to join the conversation?
$DY said backlog at the end of 3Q16 was $5.649Bil versus $5.056Bil at the end of 2Q16, an increase of approx. $595MM. Of this backlog, approx. $2.212Bil is expected to be completed in the next 12 months. $DY continues to anticipate substantial future opportunities across a broad array of its customers.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.